TABLE 1:
Lipid (class1) biologic vs. synthetic | Chain length2 | Structure | Response3 | Refs. |
---|---|---|---|---|
αGalCer (GSL) self |
C18 C24:l |
IFN-γ, IL-4 | 56 | |
Agel 9b (GSL) Agelas mauritianus |
C17 (C16-Me) phyto C24 |
Anti-tumor; Agelas mauritianus | 286,287 | |
KRN7000 αGalCer (GSL) synthetic |
C18-phyto C26 |
IFN-γ IL-4 and other cytokines | 236 | |
αCGal-Cer (GSL) synthetic |
C18-phyto C26 |
Weak (mo4)-to-none (hu); IFN-γ | 288 | |
OCH (GSL) synthetic |
C9-phyto C24 |
Weak (mo)-to-none (hu); IL-4 (low-to-no IFN-γ) | 115 | |
C20-diene (GSL) synthetic |
C18-phyto C20:2 |
IL-4 (low-to-no IFN-γ) | 114 | |
αGalCer (GSL) Bacteroides fragilis |
CI7-C3OH C17 |
Stimulatory and inhibitory based on sphanganine branching | 27,33,289 | |
αGalU Cer (GSL) Sphingomonas spp. |
C18-phyto C14 |
Weak IFN-γ | 30–32 | |
Asp B (GSL) Aspergillus fumigatus |
C20:2-C9 Me C16-C2 OH |
Weak agonist | 26 | |
αGlc-6-acyl-Chol Helicobacter pylori |
C14 | Activates a small NKT cell subset (mo) | 34 | |
βGalCer (GSL) self |
C18 C24:l |
Weak agonist | 290,291 | |
iGb3 (GSL) self |
C18-C24 | Weak (mo)-to-no (hu) response | 255 | |
αGal-DAG (GGL) Borrelia burgdorferi |
sn1-ClZA sn2-C16 |
Weak agonist (mo) | 29 | |
αGlc-DAG (GGL) Streptococcus pneumoniae |
sn1-C18:1 sn2-C16 |
Weak agonist | 28 | |
PtdIno (GPL) self |
sn1-C18:1 sn2-C18:1 |
Week agonist (mo) | 59,292 | |
Plasma-logen (GPL) self |
sn1-C16 vinyl-ether sn2-lyso |
Agonist for positive selection (mo) | 293 | |
Lyso-PtdCho (GPL) self |
sn1-C16 sn2-lyso |
Weak (hu)-to-no (mo) GM-CSF (no IL-4, IFN-γ) response | 58 |
Agel, agelasphin; Asp B, asparamide B; Chol, cholesterol; DAG, diacylglycérol; GalCer, galactosylceramide; GalUCer, galacturonosylceramide; GlcCer, glucosylceramide; PtdCho, phosphatidylcholine; PtdIno, phosphatidylinositol; sn, stereo nomenclature for glycerolipids GGL, glycoglycerolipid; GPL, glycerophospholipid; GSL, glycosphingolipid
Sphingosine/phytosphingosine chain length indicated first and N-acyl chain length second
Agonist strength based on ref295
mo, mouse; hu, human